- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRSP
Recent news which mentions CRSP
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
From InvestorPlace
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
January 27, 2023
From Motley Fool
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
January 25, 2023
From InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
From InvestorPlace
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
January 22, 2023
From Motley Fool
3 Smart Stocks to Buy if a Recession Is on the Way
January 21, 2023
From Motley Fool
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
From InvestorPlace
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
January 18, 2023
From InvestorPlace
5 Reasons to Buy Vertex Pharmaceuticals Now
January 18, 2023
From Motley Fool
2 Stocks Down More Than 25% to Buy Right Now
January 16, 2023
From Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
January 14, 2023
From Motley Fool
5 Potentially Explosive Stocks to Buy in 2023
January 13, 2023
From Motley Fool
More Likely to 5X First: CRISPR Therapeutics vs. InMode
January 12, 2023
From Motley Fool
2 Growth Stocks You May Regret not Buying Right Now
January 11, 2023
From Motley Fool
Can Cathie Wood Bounce Back in 2023?
January 11, 2023
From Motley Fool
2 Supercharged Stocks to Buy Right Now That Could Soar in 2023
January 11, 2023
From Motley Fool
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years
January 07, 2023
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
January 04, 2023
From Benzinga
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Rich Over Time
January 04, 2023
From Motley Fool
3 Growth Stocks That Could Skyrocket 50% or More In 2023, According to Wall Street
December 31, 2022
From Motley Fool
From Motley Fool
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
December 29, 2022
From Motley Fool
5 Unstoppable Trends to Invest $5,000 in for 2023
December 29, 2022
From Motley Fool
Could CRISPR Therapeutics Help You Become a Millionaire?
December 27, 2022
From Motley Fool
Is Vertex Pharmaceuticals a Buy?
December 27, 2022
From Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
December 24, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.